Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.8%

4 terminated/withdrawn out of 51 trials

Success Rate

73.3%

-13.2% vs industry average

Late-Stage Pipeline

27%

14 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

Phase 3
9(30.0%)
N/A
7(23.3%)
Phase 2
6(20.0%)
Phase 4
5(16.7%)
Phase 1
2(6.7%)
Early Phase 1
1(3.3%)
30Total
Phase 3(9)
N/A(7)
Phase 2(6)
Phase 4(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (51)

Showing 20 of 51 trials
NCT04478292Phase 3Recruiting

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Role: collaborator

NCT07495176Not ApplicableCompleted

USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias

Role: lead

NCT05681260Phase 3Recruiting

Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

Role: collaborator

NCT04794595Recruiting

Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children

Role: collaborator

NCT03948048Recruiting

Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

Role: collaborator

NCT04937907Phase 2Completed

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

Role: lead

NCT04923828Recruiting

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Role: collaborator

NCT05279664Phase 2Active Not Recruiting

RIC-NEC Randomized Controlled Trial

Role: collaborator

NCT07239895Early Phase 1Recruiting

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

Role: collaborator

NCT07278674Active Not Recruiting

Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma(CSHEIN)

Role: lead

NCT07249138Completed

Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study

Role: collaborator

NCT06489951Not ApplicableCompleted

Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker

Role: collaborator

NCT03255694Phase 2Active Not Recruiting

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Role: collaborator

NCT04905537Recruiting

Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness

Role: collaborator

NCT03647852Not ApplicableRecruiting

Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura

Role: collaborator

NCT05850546Phase 3Not Yet Recruiting

Rituximab in the First Episode of Paediatric Nephrotic Syndrome

Role: collaborator

NCT04198181Active Not Recruiting

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

Role: collaborator

NCT06410833Phase 4Recruiting

Belimumab After Rituximab in Resistant Primary Juvenile SS

Role: collaborator

NCT05381363Phase 1Terminated

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children

Role: collaborator

NCT03015974Unknown

Registry of IgA Nephropathy in Chinese Children

Role: collaborator